Skip to main content

Table 1 Comparison of demographic, treatment, and cancer-related variables between AM- recommended treatment regimen patients and non-AM recommended treatment regimen patients

From: Barriers and challenges in integration of anthroposophic medicine in supportive breast cancer care

Characteristic Total cohort N = 341, n (%) AM group N = 56, n (%) Non-AM group N = 285, n (%) P value
Age [Mean in years ± SD (median)] 62.26 ± 12.58 (63) 64.05 ± 11.55 (64.5) 61.91 ± 12.77 (63) 0.24
Sex
  Male 84 (24.6) 12 (21.4) 72 (25.3) 0.63
  Female 257 (75.4) 44 (78.6) 213 (74.7)
Main language*:
  Hebrew 243 (73.4) 47 (85.5) 196 (71.0) Hebrew vs. non-Hebrew
  Arabic 32 (9.7) 3 (5.5) 29 (10.50)
  Russian 56 (16.9) 5 (9.1)   P = 0.029
Country of birth*
  Israel 157 (48.2) 28 (52.8) 129 (47.3) Israeli-born vs. others
  Europe/America 84 (25.8) 13 (24.5) 71 (26.0)
  Asia/Africa 30 (9.2) 6 (11.3) 24 (8.8) P = 0.55
  Former USSR 55 (16.9) 6 (11.3) 49 (17.9)
Residence distance*
  Haifa** 134 (39.3) 21 (37.5) 113 (39.6) 0.88
  Suburbs** 130 (38.1) 21 (37.5) 109 (38.2)
  Periphery** 77 (22.6) 14 (25.0) 63 (22.1)
Cancer sites*
  Breast 138 (41.8) 24 (44.4%) 114 (41.3%) 0.76
  Gynecological 65 (19.7%) 13 (24.1%) 52 (18.8%) 0.36
  Gastrointestinal 78 (23.6%) 10 (18.5%) 68 (24.6%) 1.00
  Prostate + urologic 31 (9.4%) 5 (9.3%) 26 (9.4%) 0.38
  Lung 18 (5.5%) 2 (3.7%) 16 (5.8%) 0.74
Cancer recurrence*
  Recurrent 82 (24.0) 19 (33.9) 63 (22.1) 0.062
  Non-recurrent 259 (76.0) 37 (66.1) 222 (77.9)
Evidence for advanced cancer*
  Metastases 159 (46.6) 28 (50.0) 131 (46.0) 0.66
  Non-metastatic 182 (53.4) 28 (50.0) 154 (54.0)
Chemotherapy setting*
  Neoadjuvant + adjuvant 209 (65.7) 34 (61.8) 175 (66.5) 0.53
  Palliative + Curative 109 (34.3) 21 (38.2) 88 (33.5)
Non-cancer related CM use*
  Users 165 (48.5) 42 (75.0) 123 (43.3) <0.0001
  Non-users 175 (51.5) 14 (25.0) 161 (56.7)
Cancer-related CM use*
  Users 170 (50.1) 39 (69.9) 131 (46.3) 0.002
  Non-users 169 (49.9) 17 (30.4) 152 (53.7)
  1. Notes:
  2. SD standard deviation; Data analysis was performed by t-test, Fisher’s exact test, and Pearson Chi-square test.
  3. * Data is limited to the number of respondents who reported this information.
  4. **In relation to residential distance from Haifa: suburbs – up to 20 km from Haifa; periphery –beyond 20 km from Haifa.